Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-12-096477
Filing Date
2012-03-05
Accepted
2012-03-05 14:52:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G d308970dsc13g.htm SC 13G 41746
  Complete submission text file 0001193125-12-096477.txt   42942
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Subject) CIK: 0001340652 (see all company filings)

EIN.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-86723 | Film No.: 12666173
SIC: 2834 Pharmaceutical Preparations

Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address
Schall Thomas J. (Filed by) CIK: 0001423084 (see all company filings)

Type: SC 13G